WATER ISLAND CAPITAL LLC - PARATEK PHARMACEUTICALS INC ownership

PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 104 filers reported holding PARATEK PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.99 and the average weighting 0.1%.

Quarter-by-quarter ownership
WATER ISLAND CAPITAL LLC ownership history of PARATEK PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$187
+466.7%
84,697
+549.0%
0.02%
+466.7%
Q1 2023$33
-53.5%
13,050
-65.7%
0.00%
-50.0%
Q4 2022$71
-99.9%
38,060
-23.1%
0.01%
-14.3%
Q3 2022$127,000
+33.7%
49,510
+1.1%
0.01%
+16.7%
Q2 2022$95,000
-41.7%
48,987
-10.7%
0.01%
-25.0%
Q1 2022$163,000
-35.1%
54,868
-2.0%
0.01%
-42.9%
Q4 2021$251,000
+18.4%
55,972
+28.4%
0.01%
+16.7%
Q3 2021$212,000
-8.2%
43,596
+28.8%
0.01%0.0%
Q2 2021$231,000
-53.2%
33,846
-57.1%
0.01%
-65.7%
Q4 2020$494,000
-59.5%
78,859
-65.0%
0.04%
-66.3%
Q3 2020$1,219,000
-26.1%
225,409
-28.7%
0.10%
-31.6%
Q2 2020$1,650,000
+48.8%
316,053
-10.2%
0.15%
+90.0%
Q1 2020$1,109,000
-34.3%
351,941
-15.9%
0.08%
-32.2%
Q4 2019$1,687,000
-9.5%
418,681
-3.0%
0.12%
+1.7%
Q3 2019$1,865,000
-42.4%
431,724
-46.8%
0.12%
+54.7%
Q2 2019$3,240,000
-17.6%
811,882
+10.7%
0.08%
-29.9%
Q1 2019$3,930,000
+140.5%
733,296
+130.2%
0.11%
-12.3%
Q4 2018$1,634,000
-61.7%
318,518
-27.6%
0.12%
-47.2%
Q3 2018$4,265,000
+46.0%
439,726
+53.5%
0.23%
+45.3%
Q2 2018$2,922,000
-12.4%
286,500
+11.7%
0.16%
+19.5%
Q1 2018$3,335,000
+2.6%
256,500
+41.3%
0.13%
-33.5%
Q4 2017$3,249,000
+34.1%
181,500
+88.1%
0.20%
+73.9%
Q3 2017$2,422,00096,5000.12%
Other shareholders
PARATEK PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
AIGH Capital Management LLC 2,339,107$10,502,0003.20%
Telemetry Investments, L.L.C. 262,279$1,178,0001.52%
Bruce & Co., Inc. 1,443,312$6,480,0001.30%
Omega Fund Management, LLC 1,971,241$8,851,0001.25%
Worth Venture Partners, LLC 556,832$2,500,0001.24%
Abingworth LLP 1,041,131$4,654,0001.13%
1492 Capital Management LLC 491,033$2,205,0001.09%
CM Management, LLC 300,000$1,347,0001.02%
Trellus Management Company, LLC 295,000$1,325,0000.88%
GENERAL AMERICAN INVESTORS CO INC 1,306,919$5,868,0000.46%
View complete list of PARATEK PHARMACEUTICALS INC shareholders